Difference between revisions of "Squamous cell carcinoma of the lung"
Jump to navigation
Jump to search
(→IHC) |
|||
| Line 63: | Line 63: | ||
*p40 +ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | *p40 +ve.<ref name=pmid22056955>{{Cite journal | last1 = Bishop | first1 = JA. | last2 = Teruya-Feldstein | first2 = J. | last3 = Westra | first3 = WH. | last4 = Pelosi | first4 = G. | last5 = Travis | first5 = WD. | last6 = Rekhtman | first6 = N. | title = p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. | journal = Mod Pathol | volume = 25 | issue = 3 | pages = 405-15 | month = Mar | year = 2012 | doi = 10.1038/modpathol.2011.173 | PMID = 22056955 }}</ref> | ||
**p63 +ve -- less specific. | **p63 +ve -- less specific. | ||
*Calponin -ve. | *Calponin -ve. | ||
*CK5/6 +ve. | *CK5/6 +ve. | ||
Others:<ref name=pmid24126803>{{Cite journal | last1 = Montezuma | first1 = D. | last2 = Azevedo | first2 = R. | last3 = Lopes | first3 = P. | last4 = Vieira | first4 = R. | last5 = Cunha | first5 = AL. | last6 = Henrique | first6 = R. | title = A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens. | journal = Virchows Arch | volume = 463 | issue = 6 | pages = 749-54 | month = Dec | year = 2013 | doi = 10.1007/s00428-013-1488-z | PMID = 24126803 }}</ref> | |||
*CK7 -ve. | |||
*CK20 -ve. | |||
*TTF-1 -ve. | |||
**Positive in [[adenocarcinoma of the lung]]. | |||
==See also== | ==See also== | ||